These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8719496)

  • 1. Fish oil and antioxidants after heart transplantation: future strategies or eye of newt and wing of bat revisited?
    Young JB
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S250-4. PubMed ID: 8719496
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of histoincompatibility in cardiac allograft vasculopathy.
    Costanzo MR
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S180-4. PubMed ID: 8719482
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches.
    Rabinovitch M; Molossi S; Clausell N
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S116-23. PubMed ID: 8719473
    [No Abstract]   [Full Text] [Related]  

  • 4. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift.
    Mehra MR; Ventura HO; Stapleton DD; Smart FW
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S207-11. PubMed ID: 8719487
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside.
    Mehra MR; Ventura HO; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S246-9. PubMed ID: 8719495
    [No Abstract]   [Full Text] [Related]  

  • 6. The pathogenesis of graft vascular disease: implications of vascular remodeling.
    Gibbons GH
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S149-58. PubMed ID: 8719477
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease?
    Hauptman PJ; Nakagawa T; Tanaka H; Libby P
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S173-80. PubMed ID: 8719481
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiographic, pathologic, and clinical relationships in coronary artery disease in cardiac allografts.
    Haddad M; Pflugfelder PW; Guiraudon C; Novick RJ; McKenzie FN; Menkis A; Kostuk WJ
    J Heart Lung Transplant; 2005 Sep; 24(9):1218-25. PubMed ID: 16143236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coronary disease in patients after heart transplantation].
    Chomette G
    Ann Cardiol Angeiol (Paris); 1991 Dec; 40(10):593-7. PubMed ID: 1781633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does FK 506 accelerate the development of coronary artery disease in the transplanted heart as well as the native heart?
    Shibata T; Ogawa N; Koyama I; Ksaneko N; Hokazono K; Omoto R
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1145-8. PubMed ID: 7680147
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostasis, fibrinolysis, and natural anticoagulation in transplant vascular sclerosis.
    Faulk WP; Labarrere CA; Nelson DR; Pitts D
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S158-64. PubMed ID: 8719478
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac allograft vasculopathy: pathology, prevention and treatment.
    Kass M; Haddad H
    Curr Opin Cardiol; 2006 Mar; 21(2):132-7. PubMed ID: 16470150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hypercholesterolemia in accelerated transplant coronary vasculopathy: results of surgical therapy with partial ileal bypass in rabbits undergoing heterotopic heart transplantation.
    Esper E; Glagov S; Karp RB; Simonsen KK; Filer SR; Scanu AM; Sand ME
    J Heart Lung Transplant; 1997 Apr; 16(4):420-35. PubMed ID: 9154953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profiles as marker for graft vascular disease after clinical heart transplantation.
    van Besouw NM; Baan CC; Holweg CT; de Groot-Kruseman HA; Peeters AM; Balk AH; Weimar W
    Ann Transplant; 2000; 5(2):61-7. PubMed ID: 11217209
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
    Lijkwan MA; Cooke DT; Martens JM; Kown MH; Murata S; Peterson SH; Hoyt EG; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):439-45. PubMed ID: 15797746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does intracoronary ultrasound conflict with pathology? Comments from a panel discussion.
    Billingham ME
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S211-4. PubMed ID: 8719488
    [No Abstract]   [Full Text] [Related]  

  • 18. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation.
    Perrault LP; Bidouard JP; Janiak P; Villeneuve N; Bruneval P; Vilaine JP; Vanhoutte PM
    J Heart Lung Transplant; 1997 Jun; 16(6):643-57. PubMed ID: 9229295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors.
    Eisen H; Kobashigawa J; Starling RC; Valantine H; Mancini D
    Transplant Proc; 2005 May; 37(4 Suppl):4S-17S. PubMed ID: 15809102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.